AKT1 and central nervous system cancer: The PI3K/Akt/mTOR signaling pathway is a frequently disrupted pathway across different cancer types [42,43], and abnormal activation of this pathway has been associated with tumor development, progression, invasion, and metastasis [44] and is indeed activated in glioma cells [45].